Amphastar Pharmaceuticals, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US03209R1032
USD
19.00
-5.03 (-20.93%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
171.17
183.10
191.84
174.41
170.53
186.52
191.21
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
171.17
183.10
191.84
174.41
170.53
186.52
191.21
Raw Material Cost
104.68
101.25
96.82
91.91
88.45
103.16
92.55
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
6.55
6.63
6.28
6.28
6.29
6.42
6.70
Selling and Distribution Expenses
29.95
26.75
50.97
24.23
27.86
23.36
23.82
Other Expenses
1.63
1.29
1.24
0.98
1.06
0.84
1.11
Total Expenditure (Excl Depreciation)
157.54
147.50
166.52
132.23
133.24
141.38
134.17
Operating Profit (PBDIT) excl Other Income
13.600000000000001
35.6
25.299999999999997
42.199999999999996
37.3
45.099999999999994
57
Other Income
0.97
-5.96
2.48
5.13
2.75
-1.36
4.73
Operating Profit (PBDIT)
31.10
45.63
43.56
63.55
55.26
58.45
76.21
Interest
6.55
6.63
6.28
6.28
6.29
6.42
6.70
Exceptional Items
2.00
8.90
0.00
-1.70
-2.90
6.60
-7.40
Gross Profit (PBDT)
66.49
81.86
95.02
82.50
82.08
83.37
98.66
Depreciation
16.49
15.99
15.77
16.24
15.21
14.66
14.43
Profit Before Tax
10.05
31.91
21.51
39.34
30.86
43.96
47.68
Tax
3.63
7.49
4.16
8.30
5.58
6.00
7.25
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
6.42
24.43
17.35
31.03
25.29
37.96
40.43
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
6.42
24.43
17.35
31.03
25.29
37.96
40.43
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
6.42
24.43
17.35
31.03
25.29
37.96
40.43
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
773.39
788.80
776.75
757.48
751.28
732.30
727.68
Earnings per share (EPS)
0.14
0.52
0.36
0.64
0.51
0.74
0.78
Diluted Earnings per share
0.14
0.52
0.36
0.64
0.51
0.74
0.78
Operating Profit Margin (Excl OI)
7.96%
19.45%
13.2%
24.19%
21.87%
24.2%
29.83%
Gross Profit Margin
15.51%
26.16%
19.43%
31.86%
27.02%
31.43%
32.49%
PAT Margin
3.75%
13.34%
9.04%
17.79%
14.83%
20.35%
21.14%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is -6.50% vs -4.54% in Dec 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is -73.77% vs 40.23% in Dec 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is -41.67% vs 25.55% in Dec 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is 0.00% vs 4.76% in Dec 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

Compare Quarterly Results Of Amphastar Pharmaceuticals, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
171.17
136.00
35.17
25.86%
Other Operating Income
0.00
0.00
0.00
Total Operating income
171.17
136.00
35.17
25.86%
Raw Material Cost
104.68
38.00
66.68
175.47%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
6.55
21.00
-14.45
-68.81%
Selling and Distribution Expenses
29.95
88.00
-58.05
-65.97%
Other Expenses
1.63
15.80
-14.17
-89.68%
Total Expenditure (Excl Depreciation)
157.54
305.00
-147.46
-48.35%
Operating Profit (PBDIT) excl Other Income
13.63
-169.00
182.63
108.07%
Other Income
0.97
6.00
-5.03
-83.83%
Operating Profit (PBDIT)
31.10
-155.00
186.10
120.06%
Interest
6.55
21.00
-14.45
-68.81%
Exceptional Items
2.00
0.00
2.00
Gross Profit (PBDT)
66.49
98.00
-31.51
-32.15%
Depreciation
16.49
8.00
8.49
106.12%
Profit Before Tax
10.05
-184.00
194.05
105.46%
Tax
3.63
1.00
2.63
263.00%
Provisions and contingencies
0
0
0.00
Profit After Tax
6.42
-185.00
191.42
103.47%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
6.42
-185.00
191.42
103.47%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
6.42
-185.00
191.42
103.47%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
773.39
-236.00
1,009.39
427.71%
Earnings per share (EPS)
0.14
-1.84
1.98
107.61%
Diluted Earnings per share
0.14
-1.84
1.98
107.61%
Operating Profit Margin (Excl OI)
7.96%
-124.26%
0.00
132.22%
Gross Profit Margin
15.51%
-129.41%
0.00
144.92%
PAT Margin
3.75%
-136.03%
0.00
139.78%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 17.12 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -6.50% vs -4.54% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 0.41% vs -0.76% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 0.64 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -73.77% vs 40.23% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -74.70% vs -41.44% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3.01 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -41.67% vs 25.55% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -42.67% vs -15.32% in Mar 2025

Quarterly - Interest
Interest 0.66 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 0.00% vs 4.76% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 4.76% vs -26.74% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 7.96%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025